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Abstract
Background:  Granulocyte-colony-stimulating factor (G-CSF) functions as a hematopoietic
growth factor and it is responsible for leukocytosis. G-CSF-producing tumors associated with
leukocytosis include various types of malignancies.
Case presentation: We report the case of a 72-year-old man with dedifferentiated liposarcoma
characterized by dedifferentiated components of malignant fibrous histiocytoma (MFH)-like
features in addition to well-differentiated lipoma-like liposarcoma, arising from his upper arm.
Preoperative laboratory data showed leukocytosis (103,700/μl). The serum level of G-CSF was also
elevated (620 pg/ml [normal, <8 pg/ml]). Nine days after the surgery, the leukocytosis was relieved
(WBC; 6,920/μl) and the elevated serum G-CSF level was significantly decreased (G-CSF; 12 pg/
ml). One month after the surgery, leukocytosis gradually began to appear again. Three months after
the surgery metastatic lung lesions were confirmed, and the patient subsequently died of
respiratory problems. In the English literature regarding soft-tissue tumors with leukocytosis,
including the current case, we could review a total of 6 cases of liposarcoma with leukocytosis. The
subtype of these 6 liposarcoma cases was undifferentiated liposarcoma, comprising dedifferentiated
liposarcoma in 4 cases and pleomorphic liposarcoma in 2 cases.
Conclusion: Since the only other soft-tissue tumor that was associated with leukocytosis was
MFH, and since MFH is characterized by the absence of any specific differentiation, we would like
to propose a possible association between G-CSF-producing soft-tissue tumors and an
undifferentiated liposarcoma lineage, such as dedifferentiated liposarcoma or pleomorphic
liposarcoma.
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Background
Granulocyte-colony-stimulating factor (G-CSF) enhances
differentiation along the neutrophil lineage, and acceler-
ates maturation of metamyelocytes into mature neu-
trophils. Consequently, G-CSF is known to function as a
hematopoietic growth factor and it is known to be respon-
sible for leukocytosis. G-CSF-producing tumors associ-
ated with leukocytosis include various types of
malignancies. In epithelial cancers, the expression of G-
CSF has been associated with poor differentiation and
invasiveness [1-3]. However, it is a rare event among soft-
tissue tumors for leukocytosis to be associated with an ele-
vated level of serum G-CSF. Furthermore, although malig-
nant fibrous histiocytoma (MFH), which is characterized
by the absence of any distinct differentiation, has been
reported to be accompanied by leukocytosis [4-6], this is
extremely rare in the case of soft-tissue tumors with spe-
cific differentiation.
Case presentation
A 72-year-old man who suffered from a tumor in his
upper arm presented to us (Figure 1a, 1b). Body tempera-
ture was 38.1°C. Histological diagnosis of the resected
tumor was dedifferentiated liposarcoma characterized by
a well-differentiated lipoma-like liposarcoma component
(Figure 1c, 1d) and a dedifferentiated component with
MFH-like features (Figure 1e).
MRI shows a tumor with two components of high T1-weighted (a) and high T2-weighted images (b) (right portion), and of low  T1-weighted (a) and high T2-weighted images (b) (left portion) Figure 1
MRI shows a tumor with two components of high T1-weighted (a) and high T2-weighted images (b) (right portion; well-differ-
entiated components), and of low T1-weighted (a) and high T2-weighted images (b) (left portion; dedifferentiated compo-
nents). Well-differentiated components and dedifferentiated components with a distinct border (c). Well-differentiated 
components show well-differentiated lipoma-like liposarcoma with lipoblasts (arrow) (d). Dedifferentiated components are 
composed of atypical spindle cells in short fascicles, resembling MFH (bottom; left) (e). World Journal of Surgical Oncology 2007, 5:131 http://www.wjso.com/content/5/1/131
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The blood data of white blood cells and serum level of G-
CSF are summarized in Figure 2 and Table 1. Preoperative
laboratory data showed leukocytosis (103,700/μl) pre-
dominantly in the neutrophils (neutrophils; 91.5% [nor-
mal, 40–70%]). The serum level of G-CSF was also
elevated (620 pg/ml [normal, <8 pg/ml]). Leukocytosis
was relieved (white blood cells; 33,800/μl [neutrophils;
88.0%] and 6,920/μl [neutrophils; 80.6%]) and the ele-
vated serum G-CSF level was significantly decreased (G-
CSF; 44 pg/ml and 12 pg/ml), 2 and 9 days after the sur-
gery, respectively. One month after the surgery leukocyto-
sis gradually began to appear again. Three months after
the surgery, metastatic lung lesions were confirmed, and
the patient subsequently died of respiratory problems.
Expression of G-CSF (anti-G-CSF [Ab1], Calbiochem, San
Diego CA, USA) failed to be detected not only in the well-
differentiated lipoma-like liposarcoma components, but
also in the dedifferentiated components, immunohisto-
chemically (data not shown).
Table 1: Summary of blood data
D a y s  f r o m  O P E - 4 2 9 1 72 43 13 74 45 26 0
WBC (×103) 103.7 33.8 6.92 4.2 4.0 11.5 13.4 23.1 43.5 100.0
Neutrophils (%) 91.5 88.0 80.6 69.1 61.5 87.5 83.2 90.6 93.7 96.6
G-CSF(pg/ml) [normal, <8 pg/ml] 620 44 12 NA NA NA NA NA NA NA
OPE; operation, WBC; white blood cells, G-CSF; granulocyte-colony-stimulating factor, NA; not assessed
Time course of white blood cell count and serum G-CSF level Figure 2
Time course of white blood cell count and serum G-CSF level. The count of white blood cells including neutophils, and the 
serum level of G-CSF decreased after surgery.World Journal of Surgical Oncology 2007, 5:131 http://www.wjso.com/content/5/1/131
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Discussion
The leukocytosis seen in the current case with dedifferen-
tiated liposarcoma seemed to be due to stimulation by the
tumor-produced G-CSF, on the basis that both the leuko-
cytosis and the elevated level of G-CSF disappeared after
the tumor was resected. In a previous report, leukocytosis
appeared at an advanced stage, as characterized by poorly
differentiated adenocarcinoma, not in the early stage, as
characterized by well-differentiated adenocaricnoma, in
the same lesion of gastric cancer. In that gastric cancer
case, immunopositivity of G-CSF was only seen in the
poorly differentiated adenocarcinoma, not in the well-dif-
ferentiated adenocarcinoma. It is thus possible that histo-
logical changes may influence the acquisition of G-CSF-
producing ability [7]. In the current study, immunohisto-
chemical study failed to detect any expression of G-CSF. It
would seem that G-CSF-producing ability was acquired
during the course of tumor progression, because leukocy-
tosis appeared after noticeable tumor growth. It is also
possible that the components of G-CSF-producing cells
are heterogeneous in the tumor. Neoplastic cells in unex-
amined histological sections may express G-CSF, and an
immunohistochemical study would have detected G-CSF
expression.
In the English literature, including the current case, there
have been 6 cases of liposarcoma accompanied by leuko-
cytosis and associated with G-CSF expression [8-12]. Gen-
der distribution was 3 males and 3 females, while the
average age was 64.7 (range; 50–77) years. The sites were
the following; retroperitoneum in 4 cases, mesenterium in
1 case and upper arm in 1 case. The subtype of these
liposarcoma cases was dedifferentiated liposarcoma in 4
cases [10-12] and pleomorphic liposarcoma in 2 cases
[8,9]. Pleomorphic liposarcoma showed the features of
pleomorphic sarcoma, mimicking MFH, and at least
focally contained typical multivacuolated lipoblasts. In
the case of epithelial tumors, G-CSF-producing tumors
have been reported to be associated with poor differentia-
tion [1-3]. Up until now, there have been no reported
cases of well-differentiated liposarcoma with leukocyto-
sis. Therefore, it may also be true that G-CSF expression is
associated with undifferentiated liposarcoma, including
both dedifferentiated liposarcoma and pleomorphic
liposarcoma. Furthermore, it might be better to search for
dedifferentiated components in an effort to provide a pos-
sible diagnosis of dedifferentiated liposarcoma, when
well-differentiated liposarcoma is accompanied by leuko-
cytosis.
MFH has been reported to be accompanied by leukocyto-
sis, previously [4-6]. The diagnostic criteria of MFH are
defined as "pleomorphic spindle cell sarcoma with no dis-
tinct line of differentiation". The diagnosis of MFH is
commonly made by exclusion of other definitive sarco-
mas, such as liposarcoma and leiomyosarcoma. Recently,
after reassessment of pleomorphic sarcomas, the tumors
in a certain number of cases have been proved to be spe-
cific sarcomas other than MFH. Therefore, there is the pos-
sibility that the reported case of MFH with leukocytosis
actually had a liposarcoma lineage. In addition, among
soft-tissue tumors with specific differentiation, there seem
to be no reported cases with leukocytosis, besides liposar-
coma. The association between G-CSF production and
undifferentiated liposarcoma formation implies that they
share the same signaling pathways in part.
In epithelial cancers, G-CSF expression has been associ-
ated with poor differentiation and invasiveness [1-3].
Moreover, G-CSF expression was reported to be linked to
poor prognosis in patients with lung carcinoma [13]. G-
CSF has been shown to stimulate tumor cell growth and
migration in vitro [14-17]. In a similar manner, G-CSF
may have contributed to the aggressive behavior of dedif-
ferentiated liposarcoma in the current case. A transcrip-
tion factor STAT3 is a key mediator of G-CSF signaling.
STAT3 potently promotes proliferation, survival, invasion
and angiogenic effects through regulation of multiple
gene products [18-21]. Survivin is one of the STAT3-regu-
lated genes, and has an important function in regulating
the growth of cancer cells [22]. It has been indicated that
G-CSF potently activates STAT3 and STAT3-dependent
survivin expression in bladder cancer cells [23]. Further
examination would be necessary to confirm whether or
not this mechanism holds true for liposarcoma.
Conclusion
In this report, we present a case of dedifferentiated liposa-
rcoma with leukocytosis. The leukocytosis seemed to be
associated with an elevated level of serum G-CSF. We
would like to propose a possible association between G-
CSF-producing soft-tissue tumors and an undifferentiated
liposarcoma lineage, such as dedifferentiated liposarcoma
or pleomorphic liposarcoma.
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